Juxtaposition of the T-Cell Receptor α -Chain Locus (14q11) and a Region (14q32) of Potential Importance in Leukemogenesis by a 14;14 Translocation in a Patient with T-Cell Chronic Lymphocytic Leukemia and Ataxia-Telangiectasia

We describe a t(14;14)(q11;q32) translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia (AT). By using a battery of joining (J)-segment probes from the T-cell receptor (TCR) α -chain locus TCRA, three distinct Jα rearrangements were observed. One rearrangement r...

Full description

Saved in:
Bibliographic Details
Published in:Proceedings of the National Academy of Sciences - PNAS Vol. 85; no. 23; pp. 9287 - 9291
Main Authors: Davey, Michael P., Bertness, Virginia, Nakahara, Kenneth, Johnson, John P., McBride, O. Wesley, Waldmann, Thomas A., Kirsch, Ilan R.
Format: Journal Article
Language:English
Published: Washington, DC National Academy of Sciences of the United States of America 01-12-1988
National Acad Sciences
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We describe a t(14;14)(q11;q32) translocation in a patient with T-cell chronic lymphocytic leukemia and ataxia-telangiectasia (AT). By using a battery of joining (J)-segment probes from the T-cell receptor (TCR) α -chain locus TCRA, three distinct Jα rearrangements were observed. One rearrangement reflected a normal TCRA variable (V) region Vα-to-Jα recombination. The second rearrangement was caused by the translocation event itself, which joined a DNA segment from 14q32 centromeric to the immunoglobulin heavy chain locus (IGH) and a Jα gene located ≈ 75 kilobases (kb) 5′ of the TCRA constant region gene (Cα). A third rearrangement involved a 17-kb internal deletion 3′ to the translocation, a rearrangement within the Jα locus that has been observed once before in a patient with AT. Analysis of these three rearrangements underscores the increase in aberrant locus-specific recombination in lymphocytes from patients with AT. Furthermore, these studies support the view that a growth-effecting gene is present in the 14q32 region that participates in the leukemogenic process.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.85.23.9287